These final results, together with a preceding report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 aid the strategy of targeting ACKR3 as a unique way to modulate the opioid system, which could open new therapeutic avenues for opioid-similar Conditions. At that time, Microsoft Promotion https://creightonk737bgm9.p2blogs.com/profile